by Editor | Nov 17, 2024 | Abortion, News, Vaccines
The FDA announced approval of a new RSV mRNA vaccine on October 23, 2024. This vaccine was developed and tested in a collaborative effort between ModernaTX and Merck and is intended for administration to adults 60 years of age or older. The press release announcing...
by Editor | Aug 28, 2024 | Abortion, Fetal & Vaccine Research, News
We recently published an update on seasonal influenza shots and very quickly received a number of questions about the use of mRNA technology in influenza shots. A brief mention was made in the update, but a little more detail will be useful in understanding the...
by Editor | Sep 21, 2023 | Abortion, Fetal & Vaccine Research, Vaccines
Two RSV (Respiratory Syncytial Virus) vaccines have been approved in 2023 – Arexvy (GSK) and Abrysvo (Pfizer). Arexvy is recommended for adults over 60 years of age and Abrysvo has also been recommended for administration to expectant mothers between 32 and 36...